Amarin Corp Plc (AMRN)

[kimovoz]

KG, I doubt AMRN will be able to do what you are suggesting. Chances of 480M+ are astronomically low.

The guidance for 2019 was raised on July 2, 2019 to the range of 350M - 420M: https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-mid-2019-update-including-commercialization.

I think it was still rather conservative thought. From my analysis of script numbers from Sam/Raf, I think the actual revenues for 2019 will be closer to 440M. Still, nowhere near 480M.

And yes, I think that with a decent label approved in December by FDA (secondary plus partial primary) and insurers reacting in H1 2020, the 2020 revenues have a decent chance to get to 1.2B+ depending on the execution.

Kim